Compile Data Set for Download or QSAR
Report error Found 62 Enz. Inhib. hit(s) with Target = 'Catenin beta-1/B-cell CLL/lymphoma 9 protein'
TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 652137BDBM652137(US11905273, Example 2)
Affinity DataKi:  2.20E+3nMAssay Description:All experiments were performed in shite opaque 384-well plates from PerkinElmer (Waltham, MA) with an assay buffer of 25 mM HEPES (pH=7.4), 100 Mm nA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 652140BDBM652140(US11905273, Example 5)
Affinity DataKi:  4.20E+3nMAssay Description:All experiments were performed in shite opaque 384-well plates from PerkinElmer (Waltham, MA) with an assay buffer of 25 mM HEPES (pH=7.4), 100 Mm nA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588192BDBM588192((S)-(4-(3-Cyclohexyl-4-(pyrrolidin-3- yloxy)benzoy...)
Affinity DataKi:  5.20E+3nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501080BDBM50501080(CHEMBL3819506 | US12286422, Example 10)
Affinity DataKi:  5.20E+3nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588210BDBM588210(US11542254, Example canosic acid | US12286422, Exa...)
Affinity DataKi:  5.30E+3nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588210BDBM588210(US11542254, Example canosic acid | US12286422, Exa...)
Affinity DataKi:  5.30E+3nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 652139BDBM652139(US11905273, Example 4)
Affinity DataKi:  7.10E+3nMAssay Description:All experiments were performed in shite opaque 384-well plates from PerkinElmer (Waltham, MA) with an assay buffer of 25 mM HEPES (pH=7.4), 100 Mm nA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 652102BDBM652102(US11905273, Example 1)
Affinity DataKi:  8.00E+3nMAssay Description:All experiments were performed in shite opaque 384-well plates from PerkinElmer (Waltham, MA) with an assay buffer of 25 mM HEPES (pH=7.4), 100 Mm nA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 736147BDBM736147(4-(3-((S)-3-Ethyl-4-(4'-fluoro-6- (((S)-pyrrolidin...)
Affinity DataKi:  1.00E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588205BDBM588205(4-(3-((S)-3-Ethyl-4-(4'-fluoro-6- (((S)-pyrrolidin...)
Affinity DataKi:  1.00E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588209BDBM588209((S)-1-(3-Fluoro-5-(4-(4-(pyrrolidin- 3-yloxy)-3-(4...)
Affinity DataKi:  1.40E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 736151BDBM736151((S)-1-(3-Fluoro-5-(4-(4-(pyrrolidin- 3-yloxy)-3-(4...)
Affinity DataKi:  1.40E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 652138BDBM652138(US11905273, Example 3)
Affinity DataKi:  1.40E+4nMAssay Description:All experiments were performed in shite opaque 384-well plates from PerkinElmer (Waltham, MA) with an assay buffer of 25 mM HEPES (pH=7.4), 100 Mm nA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588194BDBM588194((S)-(4-(3-Fluoro-5-(piperazin-1-yl) methylcyclohex...)
Affinity DataKi:  1.60E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501081BDBM50501081(CHEMBL3819020 | US12286422, Example 12)
Affinity DataKi:  1.60E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588184BDBM588184(S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)piperaz...)
Affinity DataKi:  1.90E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 689285BDBM689285(S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)piperaz...)
Affinity DataKi:  1.90E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501086BDBM50501086(CHEMBL3818707 | US12286422, Example 8)
Affinity DataKi:  2.00E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588184BDBM588184(S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)piperaz...)
Affinity DataKi:  2.00E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 736149BDBM736149(4-(3-Fluoro-5-((5)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  2.20E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588207BDBM588207(4-(3-Fluoro-5-((5)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  2.20E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588201BDBM588201((S)-(4-(3-Cyclohexyl-4-(pyrrolidin- 3-yloxy)benzoy...)
Affinity DataKi:  2.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501083BDBM50501083(CHEMBL3819165 | US12286422, Example 19)
Affinity DataKi:  2.50E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501078BDBM50501078(CHEMBL3818097 | US12286422, Example 7)
Affinity DataKi:  3.50E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588189BDBM588189((4-(3-Fluoro-5-(((R)-pyrrolidin-3- yl)oxy)benzoyl)...)
Affinity DataKi:  3.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588193BDBM588193((S)-(4-(3-Cyclopentyl-4- (pyrrolidin-3-yloxy)benzo...)
Affinity DataKi:  3.70E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501092BDBM50501092(CHEMBL3819088 | US12286422, Example 11)
Affinity DataKi:  3.70E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588208BDBM588208((S)-1-(3-(4-(3-Cyclohexyl-4- (pyrrolidin-3-yloxy)b...)
Affinity DataKi:  3.90E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 736150BDBM736150((S)-1-(3-(4-(3-Cyclohexyl-4- (pyrrolidin-3-yloxy)b...)
Affinity DataKi:  3.90E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 736148BDBM736148(4-(3-Fluoro-5-((5)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  4.50E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588197BDBM588197((S)-(4-(3-(4,4- Dimethylcyclohexyl)-4-(pyrrolidin-...)
Affinity DataKi:  4.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588206BDBM588206(4-(3-Fluoro-5-((5)-4-(4'-fluoro-6- (((S)-pyrrolidi...)
Affinity DataKi:  4.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501093BDBM50501093(CHEMBL3818263 | US12286422, Example 15)
Affinity DataKi:  4.50E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501090BDBM50501090(CHEMBL3819332 | US12286422, Example 6)
Affinity DataKi:  4.80E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588188BDBM588188((4-(3-Fluoro-5-(((S)-pyrrolidin-3- yl)oxy)benzoyl)...)
Affinity DataKi:  4.80E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588198BDBM588198((S)-(4-(3-(4,4-Difluorocyclohexyl)- 4-(pyrrolidin-...)
Affinity DataKi:  5.30E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501082BDBM50501082(CHEMBL3818667 | US12286422, Example 16)
Affinity DataKi:  5.30E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588203BDBM588203((S)-(4-(3-Bromo-5-(piperazin-1-yl) benzoyl)piperaz...)
Affinity DataKi:  5.50E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501085BDBM50501085(CHEMBL3818058 | US12286422, Example 21)
Affinity DataKi:  5.50E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501091BDBM50501091(CHEMBL3819368 | US12286422, Example 9)
Affinity DataKi:  5.70E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588191BDBM588191((S)-(4-(3',4'-Difluoro-6-(pyrrolidin- 3-yloxy)-[1,...)
Affinity DataKi:  5.70E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588187BDBM588187((S)-(4-(3-(2-Aminoethyl)-5- fluorobenzoyl)piperazi...)
Affinity DataKi:  6.70E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501077BDBM50501077(CHEMBL3818956 | US12286422, Example 5)
Affinity DataKi:  6.70E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588202BDBM588202((S)-(4-(3-Cyclohexyl-4-(pyrrolidin- 3-yloxy)benzoy...)
Affinity DataKi:  6.90E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501084BDBM50501084(CHEMBL3818280 | US12286422, Example 20)
Affinity DataKi:  6.90E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501097BDBM50501097(CHEMBL3818207 | US12286422, Example 14)
Affinity DataKi:  7.00E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588196BDBM588196((S)-(4-(3-(4-Ethylcyclohexyl)-4- (pyrrolidin-3-ylo...)
Affinity DataKi:  7.00E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588200BDBM588200((S)-(4-(3-Chloro-5-(piperazin-l-yl) benzoyl)pipera...)
Affinity DataKi:  7.60E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50501094BDBM50501094(CHEMBL3817935 | US12286422, Example 18)
Affinity DataKi:  7.60E+4nMAssay Description:The FP experiments were performed in 96-well Microfluor 2 black plates (Waltham, MA), and the sample signals were read by a Synergy 2 plate reader (B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/27/2025
Entry Details
US Patent

TargetCatenin beta-1/B-cell CLL/lymphoma 9 protein(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 588185BDBM588185((S)-(4-(3-Fluoro-5-(piperazin-1-yl) benzoyl)pipera...)
Affinity DataKi:  8.20E+4nMAssay Description:Alphascreen Assays to Determine the Apparent Kd Values for Wild-Type and Mutant β-Catenin/BCL9 InteractionsThe experimental detail using AlphaSc...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/26/2023
Entry Details
US Patent

Displayed 1 to 50 (of 62 total ) | Next | Last >>
Jump to: